Sophie Kornowski, Pharm.D.
Board Member
Maze Therapeutics, Inc. (MAZE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sophie Kornowski, Pharm.D.
Sophie Kornowski, Pharm.D. is recorded as Board Member at Maze Therapeutics, Inc. (MAZE). Maze Therapeutics, Inc. reported in an 8-K filed August 17, 2026 that Sophie Kornowski, Pharm.D. was appointed Class I director, effective August 13, 2026.
“On August 13, 2026, the Board of Directors (the "Board") of Maze Therapeutics, Inc. (the "Company") appointed Paula A. Johnson, M.D., M.P.H. as a Class III director and Sophie Kornowski, Pharm.D. as a Class I director, in each case effective August 13, 2026 (the "Appointment Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-08-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Maze Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jason Coloma CEO, Board Member
- Hervé Hoppenot Chairman, Board Member
- Misbah Tahir CFO
- Courtney Phillips General Counsel
- Charles Homcy Board Member
- Continuing Directors Board Member
- Daniel Spiegelman Board Member
- Jonathan Lim Board Member
- Nancy C. Andrews, M.D., Ph.D. Board Member
- Neil Kumar Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.